ISG15 as a Novel Target for Tumor Immunotherapy (95.13)
Laurence M. Wood(Texas Tech University), Yvonne Paterson(University of Pennsylvania), Zhen-Kun Pan(University of Pennsylvania), Matthew M. Seavey(Brandywine Photonics (United States))
Cited by 1
Related Papers
Improved Survival in ARDS Patients Associated with a Reduction in Pulmonary Capillary Wedge Pressure
|CHEST Journal|1990|296
Elevated Expression of ISG15 in Tumor Cells Interferes with the Ubiquitin/26S Proteasome Pathway
|Cancer Research|2006|194
Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy
|Frontiers in Cellular and Infection Microbiology|2014|157
A Protease Pathway for the Repair of Topoisomerase II-DNA Covalent Complexes
|Journal of Biological Chemistry|2006|153
ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells
|Experimental Biology and Medicine|2011|102